Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

IDEAYA Biosciences (IDYA) Capital Expenditures: 2017-2024

Historic Capital Expenditures for IDEAYA Biosciences (IDYA) over the last 8 years, with Dec 2024 value amounting to $3.9 million.

  • IDEAYA Biosciences' Capital Expenditures fell 90.81% to $42,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 12.69%. This contributed to the annual value of $3.9 million for FY2024, which is 62.88% up from last year.
  • Per IDEAYA Biosciences' latest filing, its Capital Expenditures stood at $3.9 million for FY2024, which was up 62.88% from $2.4 million recorded in FY2023.
  • In the past 5 years, IDEAYA Biosciences' Capital Expenditures ranged from a high of $3.9 million in FY2024 and a low of $520,000 during FY2020.
  • Its 3-year average for Capital Expenditures is $3.2 million, with a median of $3.4 million in 2022.
  • Per our database at Business Quant, IDEAYA Biosciences' Capital Expenditures tumbled by 61.57% in 2020 and then soared by 408.46% in 2021.
  • Over the past 5 years, IDEAYA Biosciences' Capital Expenditures (Yearly) stood at $520,000 in 2020, then spiked by 408.46% to $2.6 million in 2021, then surged by 30.22% to $3.4 million in 2022, then plummeted by 31.22% to $2.4 million in 2023, then soared by 62.88% to $3.9 million in 2024.